Toggle navigation
Home
Search
Services
Blog
Contact
About
Oral Antisense Therapy for Cancer
Manoharan, Muthiah
Isis Pharmaceuticals, Inc., Carlsbad, CA, United States
Search 8 grants from Muthiah Manoharan
Search grants from Isis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanistic studies of BLyS-mediated modulation in HIV-1 Env-specific antibody responses
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD
This SBIR Phase II project seeks to continue development of a low-cost home visio
Communication in Late-stage Cancer: Exploring Hospice Decision
SBIR Phase I: Chemical Detection And Identification With Nanocrossbar Arrays
Recently added grants:
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
Defining the contributions of BRCA1, BRCA2, and RAD52 to genome stability
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA083543-01
Application #
6020093
Study Section
Special Emphasis Panel (ZRG1-SSS-1 (02))
Program Officer
Fu, Yali
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$123,990
Indirect Cost
Institution
Name
Isis Pharmaceuticals, Inc.
Department
Type
DUNS #
361949092
City
Carlsbad
State
CA
Country
United States
Zip Code
92010
Comments
Be the first to comment on Muthiah Manoharan's grant